Skip to Content

'
Michael M. Frumovitz, M. D., M.P.H., FACOG, FACS

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Fellowship Program Director, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Bio Statement

After graduating from the MD Anderson Gynecologic Oncology fellowship, Dr. Frumovitz was awarded the prestigious Fulbright Scholarship to pursue advanced laparoscopic training for the treatment of gynecologic malignancies in Lille, France.  He currently performs minimally invasive surgery for appropriate patients with cervical, endometrial, and early-stage ovarian cancers.  Dr. Frumovitz believes in working closely with the patient, the referring doctor and other subspecialty physicians in order to provide quality care through a comprehensive, multidisciplinary approach.

In addition to providing excellent patient care, Dr. Frumovitz continues to pursue his research interests which include cervical cancer, mucinous ovarian cancer, and minimally invasive surgery for gynecologic cancers.  In addition, Dr. Frumovitz has pursued development of lymphatic mapping techniques for gynecologic malignancies and currently is the Principal Investigator or Co-principal Investigator on mapping studies of the vulva, vagina, and cervix.  He has authored and co-authored numerous articles in peer-reviewed journals on these and other subjects.  In addition, he has been invited to write book chapters and review articles on a variety of topics in gynecologic oncology.  Dr. Frumovitz remains an active speaker, both nationally and internationally.

Dr. Frumovitz is a member of the American College of Obstetricians and Gynecologists and the Society of Gynecologic Oncologists where he sits on the Government Relations Committee and is board certified in Obstetrics and Gynecology and Gynecologic Oncology.  In addition, he serves as Reviewer for Gynecologic Oncology, the International Journal of Gynecologic Cancer, Obstetrics & Gynecology (popularly known as The Green Journal), and Annals of Surgical Oncology.

For appointments, please call (713) 792-8340.

Office Address

The University of Texas MD Anderson Cancer Center
1155 Herman Pressler Drive
P. O. Box 301439
Unit Number: Unit 1362
Houston, TX 77030
Room Number: CPB6.3562
Phone: 713-792-9599
Fax: (713) 792-7586

Education & Training

Degree-Granting Education

2004 The University of Texas at Houston School of Public Health, Houston, TX, MPH, Public Health
1997 University of California at Los Angeles, Los Angeles, CA, MD, Doctor of Medicine
1991 University of Pennsylvania, Philadelphia, PA, BA, History of Art

Postgraduate Training

2003-2005 Clinical Fellowship, Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Diane Bodurka, M.D.
2001-2003 Research Fellowship, Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Diane Bodurka, M.D.
1998-2001 Clinical Residency, Obstetrics and Gynecology, Columbia-Presbyterian Hospital, New York, NY, Jodi Lerner, M.D.
1997-1998 Clinical Internship, Obstetrics and Gynecology, Columbia-Presbyterian Hospital, New York, NY, Jodi Lerner, M.D.

Board Certifications

2008 American Board of Obstetrics & Gynecology Division of Gynecologic Oncology
2007 American Board of Obstetrics & Gynecology

Experience/Service

Academic Appointments

Clinical Assistant Professor, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX, 2008-2013
Assistant Professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005-2010

Administrative Appointments/Responsibilities

Chair, Gynecologic Oncology Multidisciplinary Conference, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010-2012
Resident Rotation Program Coordinator, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006-2012
Fellowship Program Assistant Director, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006-2012

Honors and Awards

2009-2013 Fellow, American College of Surgeons
2009 AAOGF Travel Award, The American Association of Obstetricians and Gynecologists Foundation
2008 AAOGF Travel Award, The American Association of Obstetricians and Gynecologists Foundation
2007 Fellow, American College of Obstetricians and Gynecologists
2005 FRS Award for Outstanding Abstract Presentation, Felix Rutledge Society
2005 Fulbright Scholarship
2004 GlaxoSmithKline Fellows' Forum Award for Outstanding Podium Presentation
2001 Howard C. Taylor Resident Teaching Award
2000 Arnold P. Gold Foundation Humanism and Excellence in Teaching Award
2000 Solan Chao, M.D. Medical Teaching Award
1999 Arnold P. Gold Teaching Award
1997 Commencement Speaker, UCLA School of Medicine
1996 Alpha Omega Alpha Medical Honor Society
1994 AMSA/HPDP Fellowship

Professional Memberships

American Association of Gynecologic Laparoscopists
Member, Gynecologic Oncology Committee, 2008-present
Member, 2006-present
American College of Obstetricians and Gynecologists
Member, 1997-present
American College of Surgeons
Member, 2008-2014
Felix Rutledge Society
Member, Executive Board, 2008-2012
Member, 2005-present
Harris County Medical Society, Houston, TX
Alternate Delegate to the Texas Medical Association representing the Houston Gynecological & Obstetrical Society, 2010
Alternate Delegate to the Texas Medical Association representing the Houston Gynecological & Obstetrical Society, 2009
Houston Gynecology and Obstetrics Society, Houston, TX
Member-at-Large, Executive Board, 2009-2011
Member, 2006-present
Society of Gynecologic Oncologists
Member, Government Relations Committee, 2005-present
Fellow Representative, Fellows Task Force Committee, 2003-2005
Member, 2001-present
Society of Laparoendoscopic Surgeons
Member, 2006-2009

Selected Publications

Peer-Reviewed Original Research Articles

1. Dunnington H., Hunter R, Frumovitz M, Smith JA. Granisetron transdermal patch for the treatment of nausea in patients undergoing cisplatin based chemotherapy for cervical cancer. Journal of Cancer Therapy. In Press.
2. Tung CS, Huh WK, Frumovitz M. Therapeutic Human Papillomavirus Vaccines for Cervical Dysplasia. Rev Ginec Onc. In Press.
3. Westin SN, Sun CC, Tung CS, Lacour RA, Meyer LA, Urbauer DL, Frumovitz MM, Lu KH, Bodurka DC. Survivors of gynecologic malignancies: impact of treatment on health and well-being. J Cancer Surviv 10(2):261-70, 4/2016. e-Pub 8/6/2015. PMCID: PMC4744585.
4. Bhosale PR, Iyer RB, Ramalingam P, Schmeler KM, Wei W, Bassett RL, Ramirez PT, Frumovitz M. Is MRI helpful in assessing the distance of the tumour from the internal os in patients with cervical cancer below FIGO Stage IB2? Clin Radiol. e-Pub 3/21/2016. PMID: 27012496.
5. Parker W, Berek JS, Pritts E, Olive D, Kaunitz AM, Chalas E, Clarke-Pearson D, Goff B, Bristow R, Taylor HS, Farias-Eisner R, Fader AN, Maxwell GL, Goodwin SC, Love S, Gibbons WE, Foshag LJ, Leppert PC, Norsigian J, Nager CW, Johnson T, Guzick DS, As-Sanie S, Paulson RJ, Farquhar C, Bradley L, Scheib SA, Bilchik AJ, Rice LW, Dionne C, Jacoby A, Ascher-Walsh C, Kilpatrick SJ, Adamson GD, Siedhoff M, Israel R, Paraiso MF, Frumovitz MM, Lurain JR, Al-Hendy A, Benrubi GI, Raman SS, Kho RM, Anderson TL, Reynolds RK, DeLancey J. An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas. J Minim Invasive Gynecol 23(3):303-8, Mar-Apr, 3/2016. e-Pub 1/8/2016. PMID: 26773577.
6. Darin MC, Gómez-Hidalgo NR, Westin SN, Soliman PT, Escobar PF, Frumovitz M, Ramirez PT. Role of indocyanine green (ICG) in sentinel node mapping in gynecologic cancer: Is fluorescence imaging the new standard? J Minim Invasive Gynecol 23(2):186-93, 2/1/2016. e-Pub 10/28/2015. PMID: 26518716.
7. Bhosale P, Ma J, Iyer R, Ramalingam P, Wei W, Soliman P, Frumovitz M, Kundra V. Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer. J Magn Reson Imaging 43(2):316-24, 2/2016. e-Pub 7/16/2015. PMCID: PMC4715803.
8. Frumovitz M. Small- and Large-Cell Neuroendocrine Cervical Cancer. Oncology (Williston Park) 30(1):70, 77-8, 93, 1/2016. PMID: 26791848.
9. Fleming ND, Soliman PT, Westin SN, dos Reis R, Munsell M, Klopp AH, Frumovitz M, Nick AM, Schmeler K, Ramirez PT. Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer. Int J Gynecol Cancer 25(8):1437-44, 10/2015. e-Pub 9/1/2015. PMCID: PMC4581897.
10. dos Reis R, Burzawa JK, Tsunoda AT, Hosaka M, Frumovitz M, Westin SN, Munsell MF, Ramirez PT. Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer. Int J Gynecol Cancer 25(7):1292-9, 9/2015. e-Pub 6/9/2015. PMCID: PMC4549160.
11. Vieira MA, Rendón GJ, Munsell M, Echeverri L, Frumovitz M, Schmeler KM, Pareja R, Escobar PF, Reis RD, Ramirez PT. Radical trachelectomy in early-stage cervical cancer: A comparison of laparotomy and minimally invasive surgery. Gynecol Oncol 138(3):585-9, 9/2015. e-Pub 6/18/2015. PMID: 26095894.
12. Smith J, Costales AB, Jaffari M, Urbauer DL, Frumovitz M, Kutac CK, Tran H, Coleman RL. Is it equivalent? Evaluation of the clinical activity of single agent Lipodox® compared to single agent Doxil® in ovarian cancer treatment. J Oncol Pharm Pract. e-Pub 7/15/2015. PMID: 26183293.
13. Burzawa J, Gonzales N, Frumovitz M. Challenges in the diagnosis and management of cervical neuroendocrine carcinoma. Expert Rev Anticancer Ther 15(7):805-10, 7/2015. e-Pub 5/17/2015. PMID: 25980782.
14. Ring KL, Ramirez PT, Conrad LB, Burke W, Wendel Naumann R, Munsell MF, Frumovitz M. Make New Friends But Keep the Old: Minimally Invasive Surgery Training in Gynecologic Oncology Fellowship Programs. Int J Gynecol Cancer 25(6):1115-20, 7/2015. PMCID: PMC4478093.
15. Sagebiel TL, Viswanathan C, Patnana M, Devine CE, Frumovitz M, Bhosale PR. Overview of the Role of Imaging in Pelvic Exenteration. Radiographics 35(4):1286-94, Jul-Aug, 7/2015. PMID: 26172363.
16. Conrad LB, Ramirez PT, Burke W, Naumann RW, Ring KL, Munsell MF, Frumovitz M. Role of Minimally Invasive Surgery in Gynecologic Oncology: An Updated Survey of Members of the Society of Gynecologic Oncology. Int J Gynecol Cancer 25(6):1121-7, 7/2015. e-Pub 4/9/2015. PMCID: PMC4478101.
17. Brown AJ, Sun CC, Urbauer D, Zhukovsky DS, Levenback C, Frumovitz M, Thaker PH, Bodurka DC, Ramondetta LM. Targeting those with decreased meaning and peace: a supportive care opportunity. Support Care Cancer 23(7):2025-32, 7/2015. e-Pub 12/18/2014. PMCID: PMC4449799.
18. Churchill SJ, Armbruster S, Schmeler KM, Frumovitz M, Greer M, Garcia J, Redworth G, Ramirez PT. Radical Trachelectomy for Early-Stage Cervical Cancer: A Survey of the Society of Gynecologic Oncology and Gynecologic Oncology Fellows-in-Training. Int J Gynecol Cancer 25(4):681-7, 5/2015. e-Pub 2/11/2015. PMID: 25675042.
19. Brown J, Taylor K, Ramirez PT, Sun C, Holman LL, Cone SM, Irwin J, Frumovitz M. Laparoscopic Supracervical Hysterectomy with Morcellation: Should it stay or should it go? J Minim Invasive Gynecol 22(2):185-92, 2/2015. e-Pub 9/19/2014. PMID: 25242233.
20. Thaker NG, Klopp AH, Jhingran A, Frumovitz M, Iyer RB, Eifel PJ. Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: Time to reconsider the FIGO staging system? Gynecol Oncol 136(2):269-73, 2/2015. e-Pub 12/16/2014. PMCID: PMC4329262.
21. Fleming ND, Frumovitz M, Schmeler KM, dos Reis R, Munsell MF, Eifel PJ, Soliman PT, Nick AM, Westin SN, Ramirez PT. Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer. Gynecol Oncol 136(1):48-53, 1/2015. e-Pub 11/18/2014. PMID: 25451695.
22. Bailey CD, Frumovitz MM. Preventing Complications in Minimally Invasive Gynecologic Surgery. Curr Obstet Gynecol Rep, 2015.
23. Frumovitz M, Jhingran A, Soliman PT, Klopp AH, Schmeler KM, Eifel PJ. Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer. Obstet Gynecol 124(6):1098-104, 12/2014. PMCID: PMC4249728.
24. Nick AM, Frumovitz MM, Soliman PT, Schmeler KM, Ramirez PT. Fertility sparing surgery for treatment of early-stage cervical cancer: open vs. robotic radical trachelectomy. Gynecol Oncol 124(2):276-80, 2/2012. e-Pub 10/27/2011. PMID: 22035808.
25. Soliman PT, Frumovitz M, Sun CC, Dos Reis R, Schmeler KM, Nick AM, Westin SN, Brown J, Levenback CF, Ramirez PT. Radical hysterectomy: A comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology. Gynecol Oncol 123(2):333-6, 11/2011. e-Pub 8/27/2011. PMID: 21872911.
26. Ndofor BT, Soliman PT, Schmeler KM, Nick AM, Frumovitz M, Ramirez PT. Rate of Port-Site Metastasis Is Uncommon in Patients Undergoing Robotic Surgery for Gynecological Malignancies. Int J Gynecol Cancer 21(5):936-40, 7/2011. e-Pub 5/30/2011. PMID: 21633306.
27. Frumovitz M, Escobar P, Ramirez PT. Minimally invasive surgical approaches for patients with endometrial cancer. Clin Obstet Gynecol 54(2):226-34, 6/2011. PMID: 21508692.
28. Nick AM, Lange J, Frumovitz M, Soliman PT, Schmeler KM, Schlumbrecht MP, dos Reis R, Ramirez PT. Rate of vaginal cuff separation following laparoscopic or robotic hysterectomy. Gynecol Oncol 120(1):47-51, 1/2011. e-Pub 9/24/2010. PMID: 20869763.
29. Zand B, Euscher ED, Soliman PT, Schmeler KM, Coleman RL, Frumovitz M, Jhingran A, Ramondetta LM, Ramirez PT. Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer. Gynecol Oncol 119(3):422-5, 12/2010. e-Pub 9/15/2010. PMID: 20837355.
30. Ramirez PT, Jhingran A, Macapinlac HA, Euscher ED, Munsell MF, Coleman RL, Soliman PT, Schmeler KM, Frumovitz M, Ramondetta LM. Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer1: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings. Cancer. e-Pub 11/16/2010. PMID: 21082702.
31. Smith AL, Frumovitz M, Schmeler KM, dos Reis R, Nick AM, Coleman RL, Ramirez PT. Conservative surgery in early-stage cervical cancer: what percentage of patients may be eligible for conization and lymphadenectomy? Gynecol Oncol 119(2):183-6, 11/2010. e-Pub 8/12/2010. PMID: 20708227.
32. Soliman PT, Frumovitz M, Spannuth W, Greer MJ, Sharma S, Schmeler KM, Ramirez PT, Levenback CF, Ramondetta LM. Lymphadenectomy during endometrial cancer staging: Practice patterns among gynecologic oncologists. Gynecol Oncol 119(2):291-4, 11/2010. e-Pub 8/12/2010. PMID: 20708226.
33. Nick AM, Schmeler KM, Frumovitz MM, Soliman PT, Spannuth WA, Burzawa JK, Coleman RL, Wei C, dos Reis R, Ramirez PT. Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery. Obstet Gynecol 116(4):956-61, 10/2010. PMID: 20859161.
34. Schmeler KM, Tao X, Frumovitz M, Deavers MT, Sun CC, Sood AK, Brown J, Gershenson DM, Ramirez PT. Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary. Obstet Gynecol 116(2 Pt 1):269-73, 8/2010. PMID: 20664385.
35. Frumovitz M, Schmeler KM, Malpica A, Sood AK, Gershenson DM. Unmasking the complexities of mucinous ovarian carcinoma. Gynecol Oncol 117(3):491-6, 6/2010. e-Pub 3/23/2010. PMID: 20332054.
36. Milam MR, Abaid L, dos Reis R, Frumovitz M, Gehrig PA, Livasy C, Broaddus RR, Ramirez PT. Microscopic Evaluation of Lymph Node-Bearing Tissue in Early Stage Cervical Cancer: A Dual Institution Review. Ann Surg Oncol 17(4):1106-10, 4/2010. e-Pub 12/29/2009. PMID: 20039215.
37. Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, Ramirez PT, Frumovitz M, Bodurka DC, Sood AK. Pelvic fractures after radiotherapy for cervical cancer: implications for Survivors. Cancer 116(3):625-630, 2/1/2010. e-Pub 1/2010. PMID: 20052724.
38. Kobayashi K, Ramirez PT, Kim EE, Levenback CF, Rohren EM, Frumovitz M, Mar MV, Gayed IW. Sentinel Node Mapping in Vulvovaginal Melanoma Using SPECT/CT Lymphoscintigraphy. Clin Nucl Med 34(12):859-61, 12/2009. PMID: 20139817.
39. Frumovitz M, Sun CC, Schmeler KM, Deavers MT, Dos Reis R, Levenback CF, Ramirez PT. Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol 114(1):93-99, 7/2009. PMID: 19546764.
40. Ricks AM, Han LY, Rashid A, Frumovitz M. Gallbladder carcinoma presenting as a pelvic mass with elevated serum testosterone: A case report. J Reprod Med 54(4):259-260, 4/2009. PMID: 19438170.
41. Mabrouk M, Frumovitz M, Greer M, Sharma S, Schmeler KM, Soliman PT, Ramirez PT. Trends in laparoscopic and robotic surgery among gynecologic oncologists: A survey update. Gynecol Oncol 112(3):501-5, 3/2009. e-Pub 1/12/2009. PMID: 19138793.
42. Kitahara S, Walsh C, Frumovitz M, Malpica A, Silva EG. Vascular Pseudoinvasion in Laparoscopic Hysterectomy Specimens for Endometrial Carcinoma: A Grossing Artifact? Am J Surg Pathol 33(2):298-303, 2/2009. e-Pub 11/3/2008. PMID: 18987543.
43. Suri A, Frumovitz M, Milam MR, dos Reis R, Ramirez PT. Preoperative pathologic findings associated with residual disease at radical hysterectomy in women with stage IA2 cervical cancer. Gynecol Oncol 112(1):110-3, 1/2009. e-Pub 10/25/2008. PMID: 18952270.
44. Frumovitz M, Soliman PT, Greer M, Schmeler KM, Moroney J, Bodurka DC, Ramirez PT. Laparoscopy training in gynecologic oncology fellowship programs. Gynecol Oncol 111(2):197-201, 11/2008. e-Pub 9/20/2008. PMID: 18804849.
45. Frumovitz M, Sun CC, Jhingran A, Schmeler KM, Dos Reis R, Milam MR, Soliman PT, Taylor K, Ramirez PT. Radical hysterectomy in obese and morbidly obese women with cervical cancer. Obstet Gynecol 112(4):899-905, 10/2008. PMID: 18827134.
46. Obermair A, Gebski V, Frumovitz M, Soliman PT, Schmeler KM, Levenback C, Ramirez PT. A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer. J Minim Invasive Gynecol 15(5):584-8, Sep-Oct, 9/2008. PMID: 18722970.
47. Ramirez PT, Soliman PT, Schmeler KM, dos Reis R, Frumovitz M. Laparoscopic and robotic techniques for radical hysterectomy in patients with early-stage cervical cancer. Gynecol Oncol 110(3 Suppl 2):S21-4, 9/2008. e-Pub 5/19/2008. PMID: 18486966.
48. Euscher ED, Malpica A, Atkinson EN, Levenback CF, Frumovitz M, Deavers MT. Ultrastaging Improves Detection of Metastases in Sentinel Lymph Nodes of Uterine Cervix Squamous Cell Carcinoma. Am J Surg Pathol 32(9):1336-43, 9/2008. PMID: 18670356.
49. Ramirez PT, Frumovitz M, Dos Reis R, Milam MR, Bevers MW, Levenback CF, Coleman RL. Modified uterine manipulator and vaginal rings for total laparoscopic radical hysterectomy. Int J Gynecol Cancer 18(3):571-5, May-Jun, 5/2008. e-Pub 8/10/2007. PMID: 17692091.
50. Frumovitz M, Levenback CF. Lymphatic mapping and sentinel node biopsy in vulvar, vaginal, and cervical cancers. Oncology (Williston Park) 22(5):529-36; discussion 538-9, 542-3, 4/30/2008. PMID: 18533402.
51. Frumovitz M, Gayed IW, Jhingran A, Euscher ED, Coleman RL, Ramirez PT, Levenback CF. Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol 108(3):478-81, 3/2008. e-Pub 1/10/2008. PMID: 18190952.
52. dos Reis R, Frumovitz M, Milam MR, Capp E, Sun CC, Coleman RL, Ramirez PT. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: An outcomes analysis. Gynecol Oncol 107(3):458-63, 12/2007. e-Pub 9/12/2007. PMID: 17854872.
53. Frumovitz M, dos Reis R, Sun CC, Milam MR, Bevers MW, Brown J, Slomovitz BM, Ramirez PT. Comparison of total laparoscopic and abdominal radical hysterectomy for patients with early-stage cervical cancer. Obstet Gynecol 110(1):96-102, 7/2007. PMID: 17601902.
54. Milam MR, Frumovitz M, dos Reis R, Broaddus RR, Bassett RL, Ramirez PT. Preoperative lymph-vascular space invasion is associated with nodal metastases in women with early-stage cervical cancer. Gynecol Oncol 106(1):12-5, 7/2007. e-Pub 5/10/2007. PMID: 17498783.
55. Leblanc E, Narducci F, Frumovitz M, Lesoin A, Castelain B, Baranzelli MC, Taieb S, Fournier C, Querleu D. Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma. Gynecol Oncol 105(2):304-11, 5/2007. e-Pub 1/29/2007. PMID: 17258799.
56. Frumovitz M, Sood AK. Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies. Gynecol Oncol 104(3):768-78, 3/2007. PMCID: PMC1851902.
57. Frumovitz M, Bodurka DC, Broaddus RR, Coleman RL, Sood AK, Gershenson DM, Burke TW, Levenback CF. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol 104(1):100-3, 1/2007. e-Pub 9/11/2006. PMID: 16963111.
58. Slomovitz BM, Sun CC, Frumovitz M, Soliman PT, Schmeler KM, Pearson HC, Berenson A, Ramirez PT, Lu KH, Bodurka DC. Are women ready for the HPV vaccine? Gynecol Oncol 103(1):151-4, 10/2006. e-Pub 3/21/2006. PMID: 16551476.
59. Slomovitz BM, Ramirez PT, Frumovitz M, Soliman PT, Bevers M, Coleman RL, Levenback C. Electrothermal bipolar coagulation for pelvic exenterations. Gynecol Oncol 102(3):534-6, 9/2006. e-Pub 2/17/2006. PMID: 16483643.
60. Zighelboim I, Ramirez PT, Gao F, Slomovitz BM, Sun C, Frumovitz M, Jhingran A, Levenback C. Retroperitoneal lymph node resection in patients with cervical cancer. Surg Oncol 15(2):79-83, 8/2006. e-Pub 10/10/2006. PMID: 17035002.
61. Elting LS, Cooksley C, Bekele BN, Frumovitz M, Avritscher EB, Sun C, Bodurka DC. Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants. Cancer 106(11):2452-8, 6/1/2006. PMID: 16639738.
62. Frumovitz M, Coleman RL, Gayed IW, Ramirez PT, Wolf JK, Gershenson DM, Levenback CF. Usefulness of preoperative lymphoscintigraphy in patients who undergo radical hysterectomy and pelvic lymphadenectomy for cervical cancer. Am J Obstet Gynecol 194(4):1186-93; discussion 1193-5, 4/2006. PMID: 16580331.
63. Frumovitz M, Gershenson DM. Fertility-sparing therapy for young women with endometrial cancer. Expert Rev Anticancer Ther 6(1):27-32, 1/2006. PMID: 16375641.
64. Frumovitz M, Ramirez PT, Levenback C. Lymphatic mapping and sentinel node detection in gynecologic malignancies of the lower genital tract. Curr Oncol Rep 7(6):435-43, 11/2005. PMID: 16221380.
65. Sun CC, Frumovitz M, Bodurka DC. Quality of life and gynecologic malignancies. Curr Oncol Rep 7(6):459-65, 11/2005. PMID: 16221383.
66. Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, Eifel P, Bevers TB, Levenback CF, Gershenson DM, Bodurka DC. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol 23(30):7428-36, 10/20/2005. PMID: 16234510.
67. Marquez RT, Baggerly KA, Patterson AP, Liu J, Broaddus R, Frumovitz M, Atkinson EN, Smith DI, Hartmann L, Fishman D, Berchuck A, Whitaker R, Gershenson DM, Mills GB, Bast RC, Lu KH. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res 11(17):6116-26, 9/1/2005. PMID: 16144910.
68. Hoekstra AV, Riben MW, Frumovitz M, Liu J, Ramirez PT. Well-differentiated papillary mesothelioma of the peritoneum: a pathological analysis and review of the literature. Gynecol Oncol 98(1):161-7, 7/2005. PMID: 15894368.
69. Martínez-Román S, Frumovitz M, Deavers MT, Ramirez PT. Metastatic carcinoma of the gallbladder mimicking an advanced cervical carcinoma. Gynecol Oncol 97(3):942-5, 6/2005. e-Pub 4/13/2005. PMID: 15943996.
70. Frumovitz M, Singh DK, Meyer L, Smith DH, Wertheim I, Resnik E, Bodurka DC. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol 95(3):463-8, 12/2004. PMID: 15581947.
71. Ramirez PT, Frumovitz M, Wolf JK, Levenback C. Laparoscopic port-site metastases in patients with gynecological malignancies. Int J Gynecol Cancer 14(6):1070-7, 11/2004. PMID: 15571612.
72. Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol 95(1):133-8, 10/2004. PMID: 15385122.
73. Frumovitz M, Slomovitz BM, Singh DK, Broaddus RR, Abrams J, Sun CC, Bevers M, Bodurka DC. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. J Am Coll Surg 199(3):388-93, 9/2004. PMID: 15325608.
74. Frumovitz M, Ramirez PT, Greer M, Gregurich MA, Wolf J, Bodurka DC, Levenback C. Laparoscopic training and practice in gynecologic oncology among Society of Gynecologic Oncologists members and fellows-in-training. Gynecol Oncol 94(3):746-53, 9/2004. PMID: 15350368.
75. Frumovitz M, Ramirez PT, Tortolero-Luna G, Malpica A, Eifel P, Burke TW, Levenback C. Characteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer. Gynecol Oncol 92(1):205-10, 2004. PMID: 14751159.
76. Frumovitz MM. Thomas Eakins' Agnew Clinic. a study of medicine through art. Obstet Gynecol 100(6):1296-300, 12/2002. PMID: 12468177.
77. Lindheim SR, Frumovitz M, Sauer MV. Recruitment and screening policies and procedures used to establish a paid donor oocyte registry. Hum Reprod 13(7):2020-4, 7/1998. PMID: 9740470.
78. Wayne NL, Frumovitz M. Calcium influx following onset of electrical afterdischarge is not required for hormone secretion from neuroendocrine cells of Aplysia. Endocrinology 136(1):369-72, 1995. PMID: 7828555.
79. Braunstein GD, Frumovitz M, Do L, Seliktar J, Gonzales E. The beta-core fragment of chorionic gonadotropin is not complexed to macromolecules in amniotic fluid. J Clin Endocrinol Metab 78(6):1349-53, 6/1994. PMID: 7515386.

Invited Articles

1. Ramirez PT, Schmeler KM, Soliman PT, Frumovitz M. Fertility preservation in patients with early cervical cancer: Radical trachelectomy. Gynecol Oncol 110(3 Suppl 2):S25-8, 9/2008. e-Pub 5/23/2008. PMID: 18501409.
2. Frumovitz M, Ramirez PT, Levenback CF. Lymphatic mapping and sentinel lymph node detection in women with cervical cancer. Gynecol Oncol 110(3 Suppl 2):S17-20, 9/2008. e-Pub 5/27/2008. PMID: 18502488.
3. Frumovitz M, Ramirez PT. Total laparoscopic radical hysterectomy: Surgical technique and instrumentation. Gynecol Oncol 104(2 Suppl 1):S13-S16, 2/2007. e-Pub 12/8/2006. PMID: 17157362.
4. Coleman RL, Frumovitz M, Levenback CF. Current perspectives on lymphatic mapping in carcinomas of the uterine corpus and cervix. J Natl Compr Canc Netw 4(5):471-8, 5/2006. PMID: 16687095.
5. Sun CC, Frumovitz M, Bodurka DC. Quality of life and gynecologic malignancies. Curr Oncol Rep 7(6):459-465, 11/2005.

Editorials

1. Frumovitz M, Ramirez PT. Sentinel Nodes in Cervical Cancer: Surgical Innovation Outside the Ivory Towers. Ann Surg Oncol 22(6):1759-60, 6/2015. e-Pub 12/2014. PMID: 25465379.
2. Ramirez PT, Frumovitz M. Optimizing sentinel node identification: A step towards novel tools and improved strategies-Exciting times are here! J Minim Invasive Gynecol 22(2):153-4, 2/2015. e-Pub 12/2014. PMID: 25527326.
3. Frumovitz M. Laparoscopic Total Hysterectomy vs Supracervical Hysterectomy: Turn, Turn, Turn. J Minim Invasive Gynecol 17(6):669-70, Nov-Dec, 11/2010. PMID: 20955976.
4. Frumovitz M, Levenback CF. Is lymphatic mapping in uterine cancer feasible? Ann Surg Oncol 15(7):1815-7, 7/2008. e-Pub 5/13/2008. PMID: 18473144.
5. Bodurka DC, Sun CC, Frumovitz MM. Quality of life in cervix cancer survivors--what matters the most in the long-term? Gynecol Oncol 97(2):307-9, 5/2005. PMID: 15863122.

Abstracts

1. Frumovitz MM, Burzawa JK, Coleman RL, Reddy SK, Astsaturov I, Millis SZ, Brown J. Identifying therapeutic options in small cell cervical cancer by multiplatform evaluation of biomarker alterations. 46th Annual Meeting of the Society of Gynecologic Oncologists, 2015.
2. Oughli HA, Balakrishan N, Munsell MF, Shiozaki T, Frumovitz MM, Soliman PT, Schmeler KM, Ramirez PT, Nick AM, O’Brien BJ, Westin SN. Paraneoplastic Neurological Syndrome in Ovarian Carcinoma. 46th Annual Meeting of the Society of Gynecologic Oncologists, 2015.
3. Soliman PT, Westin SN, Luna CCL, Diounb S, Frumovitz M, Nick AM, Fleming ND, Ramirez PT, Levenback CF, Lu KH. Sentinel Lymph Mapping accurately identifies positive nodes in women with high risk endometrial cancer. 46th Annual Meeting of the Society of Gynecologic Oncologists, 2015.
4. Sun CC, Jingran A, Ramondetta LM, Eifel PJ, Crane CH, Phan AT, Urbauer D, Frumovitz MM, Elting LS, Bodurka DC. GYN vs GI patients: Preferences (prefs) over time for chemoradiation (chemoXRT) side effects (SE) using visual analog scale (VAS) and time trade-off (TTO). ASCO Annual Meeting 2010, 6/2010.
5. Bodurka DC, Jhingran A, Ramondetta LM, Eifel PJ, Crane CH, Phan AT, Urbauer D, Frumovitz MM, Elting LS, Sun CC. Visual analog scale (VAS) and time trade-off (TTO) preferences for side effects (SE) of chemoradiation (chemoXRT): A comparison of patients (pts) and caregivers (CG). ASCO Annual Meeting 2010, 6/2010.
6. Smith A, Frumovitz M, Schmeler K, dos Reis R, Ramirez P. Conservative surgery in early cervical cancer: How many patients may be eligible?. Gynecol Oncol 116(3, Supplement 1):S30 (#74), 3/2010.
7. Soliman P, Frumovitz M, Spannuth W, Greer M, Schmeler K, Ramirez P, Levenback C, Ramondetta L. Lymph node evaluation as part of surgical staging for endometrial cancer: Practice patterns among SGO members. Gynecol Oncol 116(3, Supplement 1):S73 (#181), 3/2010.
8. Schmeler K, Tao X, Frumovitz M, Deavers M, Sun C, Sood A, Brown J, Gershenson D, Ramirez P. Prevalence of lymph node involvement in primary mucinous carcinoma of the ovary. Gynecol Oncol 116(3, Supplement 1):S112-113 (#286), 3/2010.
9. Nick A, Schmeler K, Frumovitz M, Soliman P, Spannuth W, Burzawa J, dos Reis R, Ramirez P. Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery. Gynecol Oncol 116(3, Supplement 1):S148 (#383), 3/2010.
10. Burzawa JK, Schmeler KM, Soliman PT, Lacour RA, Meyer, LA, Bevers MW, Frumovitz M, Pustilnik TB, Brown J, Anderson ML, Ramondetta LR, Tortolero-Luna G, Gershenson DM, Lu, KH. Prospective, population-based evaluation of insulin resistance, polycystic ovary syndrome and metabolic syndrome in a cohort of patients with endometrial cancer. Gynecol Oncol 112 (Supp 1)(S85), 2009.
11. Milam MR, Abaid L, Gehrig PH, dos Reis R, Livasy C, Frumovitz M, Brown J, Broaddus RR, Ramirez PT. Does microscopic nodal count improve detection of nodal metastasis in early stage cervical cancer?. Gynecol Oncol 108:S99, 2008.
12. Brown J, Bevers MW, Ramirez PT, Frumovitz M. Hand-Assisted laparoscopic splenectomy (Video). J Minim Invasive Gynecol 15(6 Supplement):S32, 2008.
13. Frumovitz M, Greer M, Soliman PT, Schmeler KM, Moroney J, Bodurka DC, Ramirez PT. Laparoscopic training and projected practice among fellows-in-training in gynecologic oncology. J Minim Invasive Gynecol 15(6 Supplement):S91, 2008.
14. Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, Ramirez PT, Frumovitz MM, Bodurka DC, Sood AK. Pelvic fractures following radiation therapy for cervical cancer: Implications for survivors. ASCO 2008 Annual Meeting, 2008.
15. Sun CC, Aguilliard J, Jhingran A, Eifel P, Crane CH, Phan A, Ramondetta LM, Frumovitz MF, Elting L, Bodurka DC. Preferences for side effects of chemoradiation: focus on nausea and vomiting. Support Care Cancer 16(6):734, 2008.
16. Frumovitz M, Greer M, Soliman PT, Schmeler KM, Moroney J, Ramirez PT. Robotic surgery practice and training in gynecologic oncology. J Minim Invasive Gynecol 15(6 Supplement):S130, 2008.
17. Soliman PT, Schmeler KM, Frumovitz M, Milam MR, dos Reis R, Levenback C, Ramirez PT. The learning curve with minimally invasive radical hysterectomy: laparoscopy versus robotic assisted procedures. J Minim Invasive Gynecol 15(6 Supplement):S37, 2008.
18. Schmeler KM, Frumovitz M, dos Reis R, Bevers MW. The use of a vessel-sealant device (LigaSure) compared with ultrasonic surgical instrumentation (Harmonic Ace) in radical hysterectomy for cervical cancer. J Minim Invasive Gynecol 14:S90-S91, 12/2007.
19. Frumovitz M, dos Reis R, Sun CC, Brown J, Milam MR, Bevers M, Ramirez PT. A comparison of total laparoscopic hysterectomy and abdominal radical hysterectomy for cervical cancer. Gynecol Oncol 104:21, 2007.
20. Milam MR, dos Reis R, Frumovitz M, Ramirez PT. Preoperative lymph-vascular space invasion is associated with nodal metastases in women with early-stage cervical cancer. Gynecol Oncol 104:214, 2007.
21. Frumovitz M, Sun CC, Brown J, dos Reis R, Milam M, Levenback CL, Ramirez PT. Total laparoscopic radical hysterectomy in an academic vs community setting. J Minim Invasive Gynecol 14:48, 2007.
22. Euscher E, Frumovitz M, Malpica A. Ultrastaging improves detection of metastases in sentinel lymph nodes of patients with cervical carcinoma. Gynecol Oncol 104:37, 2007.
23. Slomovitz BM, Sun CC, Frumovitz M, Soliman PT, Pearson HC, Berenson A, Bodurka DC. Are women ready for the cervical cancer vaccine?. Gynecol Oncol 96:912, 2004.
24. Frumovitz M, Slomovitz BM, Broaddus RR, Abrams J, Sun CC, Bevers M, Bodurka DC. Endometrial cancer: To stage or not to stage, part II. Gynecol Oncol 92:487, 2004.
25. Zighelboim I, Ramirez PT, Sun CC, Frumovitz M, Jhingran A, Levenback C. Factors that preclude resection of bulky nodal metastases in patients with cervical cancer. Gynecol Oncol 96:989, 2004.
26. Frumovitz M, Ramirez PT, Greer M, Gregurich MA, Wolf JK, Bodurka DC, Levenback C. Laparoscopic practice and training among SGO members. Gynecol Oncol 92:409, 2004.
27. Frumovitz M, Ramirez PT, Greer M, Gregurich MA, Wolf JK, Bodurka DC, Levenback C. Laparoscopic training and projected practice among fellows-in-training in gynecologic oncology. Gynecol Oncol 92:410, 2004.
28. Frumovitz M, Sun CC, Schover LR, Jhingran A, Eifel PJ, Bevers TB, Levenback C, Bodurka DC. Quality of life in cervix cancer survivors: Five years posttreatment. Gynecol Oncol 92:474, 2004.
29. Frumovitz M, Coleman RL, Gayed IW, Ramirez PT, Wolf JK, Levenback C. Utility of preoperative lymphoscintigraphy in patients undergoing radical hysterectomy and pelvic lymphadenectomy for cervical cancer. Gynecol Oncol 96:990, 2004.
30. Frumovitz M, Singh DK, Smith DH, Wertheim I, Resnick E, Bodurka DC. Endometrial cancer: To stage or not to stage?. Gynecol Oncol 88:188, 2003.
31. Frumovitz M, Ramirez P, Tortolero-Luna G, Bodurka DC, Sun C, Malpica A, Levenback C. Groin recurrence in patients who underwent lymphatic mapping for vulvar malignancy. Int J Gyn Cancer 13 Suppl 1:17, 2003.
32. Ramirez PT, Frumovitz M, Wolf JK, Levenback C. Laparoscopic port-site metastases in gynecologic malignancies. JSLS 7:s3, 2003.
33. Bodurka DC, Frumovitz M, Sun CC, Ramirez PT, Bevers MW, Gershenson DM. Laparoscopy for probable ovarian cancer: Less may not be more. Gynecol Oncol 88:244, 2003.
34. Frumovitz M, Ramirez P, Bodurka DC, Delpessand E, Malpica A, Levenback C. Predictive factors for metastatic involvement of nonsentinel nodes in patients with vulvar cancer. Int J Gyn Cancer 13 Suppl 1, 2003.
35. Sun CC, Slomovitz BM, Frumovitz M, Weaver CB, Lu KH, Gershenson DM, Bodurka DC. Preference (utility) assessment in patients with gynecologic malignancies: The M.D. Anderson experience. Eur J Cancer 1(3):S16, 2003.
36. Frumovitz M, Singh DK, Wertheim I, Resnick E, Smith DH. Accuracy of intraoperative gross examination in endometrial cancer. Cancer J 8:498, 2002.
37. Frumovitz M, Singh DK, Wertheim I, Resnick E, Smith DH. Accuracy of pipelle endometrial biopsy versus dilation and curettage in patients with endometrial cancer. Cancer J 8:487, 2002.
38. Frumovitz M, Ascher-Waish C, Smith D, Wertheim I, Resnik E, Singh L. The utility of endocervical curettage in routine colposcopy of patients with satisfactory examination. Obstet Gynecol 4 Suppl 1:S15, 2001.

Book Chapters

1. Frumovitz MM. Techniques in Gynecologic Oncology. In: Atlas of Single-Port, Laparoscopic, and Robotic Surgery. Springer, 69-77, 2014.
2. Frumovitz M. Lymphatic mapping and sentinel node biopsy in gynecologic cancers. In: Textbook in Gynaecologıcal Oncology. Ed(s) Ali Ayhan, Murat Gultekın, Polat Dursun. Gunes Tıp Kıtabevleri: Ankara, Turkey, 257-259, 2009. ISBN: 978-975-277-267-0.
3. Frumovitz M, Slomovitz BM, Bodurka DC. Obstetric and gynecologic issues. In: Medical Care of Cancer Patients. Ed(s) Sai-Ching Jim Yeung, MD, PhD; Carmen P. Escalante, MD; Robert F. Gagel, MD. B. C. Decker, Inc., People's Medical Publishing House: Shelton, Connecticut, 641-646, 2009.
4. Frumovitz M, Bodurka DC. Neoplastic diseases of the vulva. In: Comprehensive Gynecology, 5th. Ed(s) Katz VL, Lentz GM, Lobo RA, Gershenson DM. Mosby Elsevier: Philadelphia, 781-800, 2007.
5. Frumovitz M, Levenback C, Coleman R. Predictive values of sentinel lymph nodes. In: Prognostic and Predictive Factors in Gynecologic Cancers. Informa UK Ltd: London, 325-336, 2007.

Books (edited and written)

1. Ramirez PT, Frumovitz MM, Abu-Rustum N. Principles of Gynecologic Oncology Surgery. Elsevier. In Press.

Letters to the Editor

1. Leblanc E, Frumovitz M, Querleu D. Reply to Lavoue. Gynecol Oncol:254-5, Mar-Apr, 4/2008. e-Pub 4/2008. PMID: 18417197.
2. Ramirez PT, Frumovitz M. Puntambekar et Al. Laparoscopic total radical hysterectomy by the Pune technique: our experience of 248 cases. J Minim Invasive Gynecol 15(2):254-5; author reply 255, Mar-Apr, 3/2008. PMID: 18313003.
3. Ramirez PT, Milam MR, Frumovitz M. Laparoscopic extraperitoneal para-aortic lymphadenectomy. Gynecol Oncol 106(2):433-4, 8/2007. e-Pub 5/23/2007. PMID: 17524458.

Manuals, Teaching Aids, Other Teaching Publications

1. Frumovitz M, Slomovitz BM, Singh DK, Broaddus RR, Abrams J, Sun CC, Bevers M, Bodurka DC. Frozen section analyses as predictors of lymphatic spread in patients with early stage uterine cancer. 2000.

Last updated: 4/15/2016